Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Class 2 Drug Alert (Action within 48 hours): Jubilant Pharmaceuticals NV and Wockhardt UK Ltd - Amlodipine 5mg and 10mg Tablets - EL (09)A/15

Document details:

Type: Drug Alert
Series No: EL (09)A/15
Audience: Healthcare professionals
Published:
Format: Electronic and paper
Size: A4
Pages: 2
Price: Free
ISBN/ISSN:
Author:
Copyright: Crown
   

Help viewing PDFs:

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

DRUG ALERT

Class 2 medicines recall
Action within 48 hours
Pharmacy and wholesaler level recall
29 June 2009 EL (09)A/15 Our ref:  MDR 55-06/09

Dear Healthcare Professional,

Jubilant Pharmaceuticals NV and Wockhardt UK Ltd

Amlodipine 5mg and 10mg Tablets

Amlodipine besilate

PL 19156/0033 and PL 19156/0034

Product distributed solely in Wockhardt UK livery

5mg Tablets
Batch Number Expiry Date Pack Size First Distributed
T7A010508 04/2011 28 tablets 27/8/08
T7A020508 04/2011 28 tablets 11/9/08
T7A030508 04/2011 28 tablets 6/11/08
T7A040508 04/2011 28 tablets 2/12/08
T7A050508 04/2011 28 tablets 24/10/08

 

10mg Tablets
Batch Number Expiry Date Pack Size First Distributed
T8A020508 04/2011 28 tablets 9/1/09


Jubilant Pharmaceuticals NV, the product marketing authorisation holder, are recalling the above products due to serious GMP deficiencies found during an inspection of their contract manufacturer.

All unused stock of the above batches should be quarantined and returned for credit.

For any Medical Information enquiries related to this case please call Jubilant Pharmaceuticals NV on 0032 487 209 973.

For enquiries related to stock returns and credit please call Wockhardt UK Customer Services on  01978  669215.

Recipients of this Drug Alert should bring this to the attention of relevant contacts by copy of this letter. Primary Care Trusts are requested to forward this to relevant clinics, General Practitioners and Community Pharmacists.

Yours faithfully
Ian Holloway
MHRA DMRC Manager

 

MHRA Distribution (further recipients by cascade):

Regional Contacts for NHS Trusts and Provider Units
Chief Pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief Pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special Hospitals
Healthcare Commission for distribution to Independent Health Care Establishments
Primary Care Trusts (England)

Page last modified: 29 June 2009